FDA.reportPublic FDA data

NDC 71104-989 - ALTUVIIIO

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
71104-989
Package NDCs from labels
71104-989-08
Manufacturer
Bioverativ Therapeutics Inc. | PPD Development Ireland Ltd. | Eurofins Lancaster Laboratories, Inc | Biogen U.S. Corporation | Rechon Life Science AB | Genzyme Corporation | Vetter Pharma Fertigung GmbH & Co. KG (Langenargen Eisenbahnstrasse) | Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Schuetzenstrasse) | Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen) | Genzyme Ireland Limited | Biogen MA Inc. | Genzyme Flanders
Effective date
2026-02-23
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
ALTUVIIIOBioverativ Therapeutics Inc. | PPD Development Ireland Ltd. | Eurofins Lancaster Laboratories, Inc | Biogen U.S. Corporation | Rechon Life Science AB | Genzyme Corporation | Vetter Pharma Fertigung GmbH & Co. KG (Langenargen Eisenbahnstrasse) | Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Schuetzenstrasse) | Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen) | Genzyme Ireland Limited | Biogen MA Inc. | Genzyme Flanders2026-02-23HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
71104-989-08ALTUVIIIO3 mL in 1 VIALPOWDER, FOR SOLUTION3 mL2000 [iU] in 3mL10

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
71104-989ALTUVIIIO (ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC-VWF-XTEN FUSION PROTEIN-EHTL) KIT [BIOVERATIV THERAPEUTICS INC.]7Unmatched20250313_01411972-df40-4ccf-88f0-d3220e5abda9.zip